DK142287B - Fremgangsmåde til rensning af et urent alkalimetalsalt af 7-(2'-thienylacetamido)-cephalosporansyre. - Google Patents
Fremgangsmåde til rensning af et urent alkalimetalsalt af 7-(2'-thienylacetamido)-cephalosporansyre. Download PDFInfo
- Publication number
- DK142287B DK142287B DK631671AA DK631671A DK142287B DK 142287 B DK142287 B DK 142287B DK 631671A A DK631671A A DK 631671AA DK 631671 A DK631671 A DK 631671A DK 142287 B DK142287 B DK 142287B
- Authority
- DK
- Denmark
- Prior art keywords
- cephalothin
- salt
- alkali metal
- sodium
- solution
- Prior art date
Links
- 229910052783 alkali metal Inorganic materials 0.000 title description 23
- -1 alkali metal salt Chemical class 0.000 title description 23
- 238000000034 method Methods 0.000 title description 16
- 239000002253 acid Substances 0.000 title description 6
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 45
- 239000012535 impurity Substances 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 21
- 239000007864 aqueous solution Substances 0.000 description 17
- 229940083555 sodium cephalothin Drugs 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- 229960000603 cefalotin Drugs 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 102000007327 Protamines Human genes 0.000 description 4
- 108010007568 Protamines Proteins 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229940001447 lactate Drugs 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 229940048914 protamine Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical class COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- UMFCIIBZHQXRCJ-NSCUHMNNSA-N trans-anol Chemical compound C\C=C\C1=CC=C(O)C=C1 UMFCIIBZHQXRCJ-NSCUHMNNSA-N 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910001513 alkali metal bromide Inorganic materials 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 150000008045 alkali metal halides Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003186 pharmaceutical solution Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 239000001521 potassium lactate Substances 0.000 description 1
- 235000011085 potassium lactate Nutrition 0.000 description 1
- 229960001304 potassium lactate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10138370A | 1970-12-24 | 1970-12-24 | |
| US10138370 | 1970-12-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK142287B true DK142287B (da) | 1980-10-06 |
| DK142287C DK142287C (cs) | 1981-03-02 |
Family
ID=22284373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK631671AA DK142287B (da) | 1970-12-24 | 1971-12-23 | Fremgangsmåde til rensning af et urent alkalimetalsalt af 7-(2'-thienylacetamido)-cephalosporansyre. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US3714154A (cs) |
| JP (1) | JPS5246238B1 (cs) |
| AT (1) | AT310947B (cs) |
| BE (1) | BE776842A (cs) |
| BG (1) | BG24674A3 (cs) |
| CA (1) | CA925864A (cs) |
| CS (1) | CS190362B2 (cs) |
| CY (1) | CY872A (cs) |
| DK (1) | DK142287B (cs) |
| ES (1) | ES398305A1 (cs) |
| FI (1) | FI56015C (cs) |
| FR (1) | FR2119747A5 (cs) |
| GB (1) | GB1318690A (cs) |
| HK (1) | HK78376A (cs) |
| HU (1) | HU162401B (cs) |
| IE (1) | IE35922B1 (cs) |
| IL (1) | IL38478A (cs) |
| LU (1) | LU64519A1 (cs) |
| MY (1) | MY7700002A (cs) |
| NL (1) | NL163790C (cs) |
| NO (1) | NO139223C (cs) |
| OA (1) | OA03935A (cs) |
| RO (1) | RO58634A (cs) |
| SE (1) | SE376920B (cs) |
| SU (1) | SU439989A3 (cs) |
| YU (1) | YU39895B (cs) |
| ZA (1) | ZA718355B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4012380A (en) * | 1974-12-10 | 1977-03-15 | Eli Lilly And Company | 7-Acylamino-3-acyl-2(or 3)cephems |
| FR2414509A1 (fr) * | 1978-01-17 | 1979-08-10 | Glaxo Group Ltd | Procede de cristallisation de cefuroxime sodique |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3218318A (en) * | 1962-08-31 | 1965-11-16 | Lilly Co Eli | 7-heterocyclic-substituted-acylamido cephalosporins |
| US3351597A (en) * | 1966-11-23 | 1967-11-07 | Lilly Co Eli | Process for acylating 7-amino cephalosporanic acid |
-
1970
- 1970-12-24 US US00101383A patent/US3714154A/en not_active Expired - Lifetime
-
1971
- 1971-06-24 YU YU3251/71A patent/YU39895B/xx unknown
- 1971-12-14 ZA ZA718355A patent/ZA718355B/xx unknown
- 1971-12-16 SE SE7116121A patent/SE376920B/xx unknown
- 1971-12-17 BE BE776842A patent/BE776842A/xx not_active IP Right Cessation
- 1971-12-17 NL NL7117414.A patent/NL163790C/xx not_active IP Right Cessation
- 1971-12-20 CY CY872A patent/CY872A/xx unknown
- 1971-12-20 GB GB5906871A patent/GB1318690A/en not_active Expired
- 1971-12-21 HU HUEI397A patent/HU162401B/hu unknown
- 1971-12-22 BG BG019299A patent/BG24674A3/xx unknown
- 1971-12-22 FI FI3653/71A patent/FI56015C/fi active
- 1971-12-22 OA OA54446A patent/OA03935A/xx unknown
- 1971-12-23 AT AT1107371A patent/AT310947B/de not_active IP Right Cessation
- 1971-12-23 NO NO4825/71A patent/NO139223C/no unknown
- 1971-12-23 IE IE1641/71A patent/IE35922B1/xx unknown
- 1971-12-23 CA CA130994A patent/CA925864A/en not_active Expired
- 1971-12-23 ES ES398305A patent/ES398305A1/es not_active Expired
- 1971-12-23 CS CS718964A patent/CS190362B2/cs unknown
- 1971-12-23 DK DK631671AA patent/DK142287B/da unknown
- 1971-12-24 SU SU1730460A patent/SU439989A3/ru active
- 1971-12-24 RO RO69184A patent/RO58634A/ro unknown
- 1971-12-24 FR FR7146605A patent/FR2119747A5/fr not_active Expired
- 1971-12-24 LU LU64519D patent/LU64519A1/xx unknown
- 1971-12-24 JP JP47004066A patent/JPS5246238B1/ja active Pending
- 1971-12-29 IL IL38478A patent/IL38478A/xx unknown
-
1976
- 1976-12-09 HK HK783/76*UA patent/HK78376A/xx unknown
-
1977
- 1977-12-30 MY MY2/77A patent/MY7700002A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Steiger | Benzoylation of amino acids | |
| PT101554B (pt) | Processo para a cristalizacao de iopamidol utilizando um butanol como solvente, iopamidol cristalino assim obtido e agentes de contraste radiograficos que o contem | |
| PT93669A (pt) | Processo para a preparacao de cefodizima dissodica | |
| Heath et al. | 488. 2-Mercaptoglyoxalines. Part I. The synthesis of ergothioneine | |
| DK142287B (da) | Fremgangsmåde til rensning af et urent alkalimetalsalt af 7-(2'-thienylacetamido)-cephalosporansyre. | |
| NO167098B (no) | Modulaer beskyttelsesstruktur for undervannsinstallasjoner. | |
| SU439989A1 (ru) | Способ выделени щелочно-металлических солей 7-/2"-тиенилацетамидо/-цефалоспорановой кислоты | |
| Levene et al. | ON THE MUTAROTATION OF PHENYLOSAZONES OF PENTOSES AND HEXOSES. | |
| KR0135979B1 (ko) | 모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염 | |
| US3875138A (en) | Process for recovering glucagon | |
| US5304677A (en) | Method for producing 2,6-dihydroxybenzoic acid | |
| US2361576A (en) | Method of refining a crude 1-naphthylacetic acid | |
| SU455952A1 (ru) | Способ очистки сульфониламидных препаратов | |
| DK167319B1 (da) | Stabilt hydrat af et penicillinderivat og fremgangsmaade til fremstilling deraf | |
| JPS5829294B2 (ja) | ロイシンおよびイソロイシンの混合物からイソロイシンを精製する方法 | |
| US2590067A (en) | Methanol complex of dehydro-l-ascorbic acid | |
| NO117505B (cs) | ||
| NO134258B (cs) | ||
| KR100325558B1 (ko) | 7-클로로퀴놀린-8-카르복실산의정제방법 | |
| US2680739A (en) | Production of sodium penicillin | |
| US3476856A (en) | Process for producing the sodium salt of nystatin and levorin | |
| US2423062A (en) | Resolution of alpha-hydroxy-beta:beta-dimethyl-gamma-butyrolactone | |
| SU738225A1 (ru) | Способ получени иодгиппурата натри -иОд131 | |
| JPS62440A (ja) | ジヒドロキシ安息香酸異性体の分離法 | |
| US2444087A (en) | Process of recovering an ascorbic acid compound |